Build a lasting personal brand

Pearson Medical Technologies Launches m:Print v4 to Enhance Pharmacy Compliance with DSCSA

By Burstable Editorial Team

TL;DR

Pearson Medical Technologies introduces M-Print bar code labeling software v4 for pharmacy drug supply chain security act (DSCSA) compliance, giving pharmacies a competitive advantage in meeting regulatory requirements.

The M-Print bar code labeling software v4 works by providing pharmacies with a comprehensive solution for labeling drugs and ensuring compliance with the DSCSA.

The introduction of M-Print bar code labeling software v4 makes the world a better place by enhancing the security and authenticity of pharmaceutical products, ultimately benefiting patients and healthcare providers.

Pharmacies can now streamline their drug labeling process and improve compliance with the DSCSA through Pearson Medical Technologies' innovative M-Print bar code labeling software v4.

Found this article helpful?

Share it with your network and spread the knowledge!

Pearson Medical Technologies Launches m:Print v4 to Enhance Pharmacy Compliance with DSCSA

Pearson Medical Technologies has launched m:Print Bar Code Labeling Software v4, a significant upgrade aimed at aiding pharmacies in meeting the stringent requirements of the Drug Supply Chain Security Act (DSCSA). This development is timely, as the pharmaceutical industry approaches the November 27, 2023 deadline for full DSCSA compliance, making the software a critical tool for pharmacies striving to adhere to these regulations.

The DSCSA, established in 2013, mandates an electronic, interoperable system to trace prescription drugs throughout the U.S. supply chain, ensuring drug integrity and patient safety. m:Print v4 addresses these needs by supporting the printing of 2D Data Matrix barcodes, which encode essential product identifiers such as the National Drug Code (NDC), serial number, lot number, and expiration date.

Among its advancements, m:Print v4 features the ability to interface with wholesaler portals, automating the download and storage of Transaction Information (TI), Transaction History (TH), and Transaction Statements (TS). This automation reduces manual data entry, lowering the risk of errors and enhancing operational efficiency for pharmacy staff.

Enhanced data management is another cornerstone of m:Print v4, offering capabilities to store and manage product master data, serial numbers, and transaction data. This comprehensive approach ensures accurate record-keeping and facilitates swift information retrieval, crucial during regulatory inspections or product recalls.

The software's redesigned user interface emphasizes user-friendliness and efficiency, aiming to minimize the learning curve for pharmacy personnel and accelerate the adoption of DSCSA-compliant processes.

By improving the tracking and management of pharmaceutical products, m:Print v4 not only aids pharmacies in compliance but also supports the DSCSA's broader objectives of safeguarding the drug supply chain and protecting patients from counterfeit or harmful drugs. This release signifies a step forward in the healthcare industry's digital transformation, setting a new benchmark for pharmacy inventory management and regulatory compliance.

For more information on how m:Print v4 can assist your pharmacy, visit https://www.pearsonmedical.com.

Curated from NewMediaWire

blockchain registration record for this content
Burstable Editorial Team

Burstable Editorial Team

@burstable

Burstable News™ is a hosted solution designed to help businesses build an audience and enhance their AIO and SEO press release strategies by automatically providing fresh, unique, and brand-aligned business news content. It eliminates the overhead of engineering, maintenance, and content creation, offering an easy, no-developer-needed implementation that works on any website. The service focuses on boosting site authority with vertically-aligned stories that are guaranteed unique and compliant with Google's E-E-A-T guidelines to keep your site dynamic and engaging.